#Japan #Tokyo #cancer detection #Yukaria #Smart Scan

Smart Scan Expands MRI Services

In a significant move for early cancer detection, Smart Scan Co., Ltd., a wholly-owned subsidiary of Yukaria Co., Ltd. based in Chiyoda, Tokyo, plans to roll out an enhanced menu for its cancer screening services, starting May 2025. The initiative aims to tackle the often-late diagnosis of pancreatic, prostate, and uterine cancers, which can progress rapidly without noticeable symptoms. Here, we delve into the details.

Overview of the Enhanced Services

Smart Scan's extended services will offer specialized screenings for various cancers using advanced MRI technology. As these cancers often exhibit minimal symptoms in their early stages, the new offerings are designed to facilitate quicker diagnoses and improve patient outcomes.

1. Pancreatic Cancer Screening

Cost: 27,000 JPY (29,700 JPY including tax)

Pancreatic cancer has a notoriously poor prognosis, partially due to its low detectability using conventional ultrasound checks. The MRI scan provides comprehensive visibility of the pancreas, making early detection more feasible. The inclusion of MRCP (Magnetic Resonance Cholangiopancreatography) will further enhance the ability to spot early signs of pancreatic and bile duct cancers, potentially leading to timely intervention.
Learn more about Pancreatic Cancer Screening

2. Prostate Cancer Screening

Cost: 27,000 JPY (29,700 JPY including tax)

Prostate cancer rates have surged among men aged 50 and above. Advanced screenings of the pelvic area via MRI can identify potential tumors, which can be crucial in preventing the progression that necessitates surgical intervention. Given the associated risks, like urinary incontinence and sexual dysfunction post-surgery, early examination becomes vital for men’s health.
Learn more about Prostate Cancer Screening

3. Uterine and Ovarian Cancer Screening

Cost: 27,000 JPY (29,700 JPY including tax)

Uterine and ovarian cancers often present no symptoms initially and can develop into serious conditions over time. Regular screenings using MRI technology will identify abnormalities, including uterine fibroids and endometriosis, before they complicate treatment options. Early detection is the cornerstone of effective management for women's health issues.
Learn more about Uterine and Ovarian Cancer Screening

Features of Smart Scan Services

• - MRI Imaging for Tumor Detection: Employing MRI allows for less invasive and more accurate screening, ensuring better patient comfort and more reliable results.
• - Online Access to Results: Patients can seamlessly check their results through a personalized web portal, streamlining the entire process from booking to follow-up.

About Smart Brain Dock

The Smart Brain Dock service utilizes MRI and CT scanners during non-operational hours at medical facilities, offering affordable and swift examinations. It specializes in identifying cerebral anomalies such as aneurysms or tumors often unnoticed until they develop significant symptoms. Check-ins and results are efficiently handled online, reducing overall wait times to about 30 minutes.

Smart Scan has conducted approximately 154,000 screenings as of March 2025, demonstrating its commitment to providing timely healthcare solutions.

For more information on Smart Dock services, visit Smart Dock

Yukaria's Vision for Healthcare Transformation

In response to Japan’s aging society and the increasing burden of social security costs, Yukaria is advancing its mission of industrializing healthcare. Focusing on stabilizing operations within hospitals and enhancing the well-being of healthcare professionals, the company aspires to improve the quality of life for patients and caregivers alike.

By leveraging AI technologies and collaborating with various stakeholders, Yukaria aims to address healthcare challenges efficiently. They have already rolled out innovative services such as Smart Scan and Yukaria Touch with the goal of revolutionizing the healthcare landscape in Japan.